Investment option ratings

Cbus has contracted Chant West and Lonsec to provide independent reviews of our investment options.

Below is a summary of the ratings we have received as well as links to the supporting reports. Click on the ratings in the table to view the corresponding report.

In order to access the reports, use the same password as the planner Quarterly Investment Updates.

Accumulation

Research House Rating(s)
Chant West1

Super Investment Rating Report (PDF)

5 Apples, Highest Quality Overall Investments

 

Covering the following options:

Growth (MySuper) - 5 Apples, Highly Recommended

High Growth - 5 Apples, Highly Recommended

Growth Plus - 5 Apples, Highly Recommended

Conservative Growth - 5 Apples, Highly Recommended

Conservative - 5 Apples, Highly Recommended

Lonsec2

Growth (MySuper) – Highly Recommended (PDF)

High Growth – Highly Recommended (PDF)

Growth Plus - Highly Recommended (PDF)

Conservative Growth - Highly Recommended (PDF)

Conservative – Highly Recommended (PDF)

Cash – Recommended (PDF)

Chant West

Chant West uses their knowledge and experience of funds to compare them in a way that’s fair and rigorous, and on an ‘apples with apples’ basis with 5 Apples being their highest grade.

5 Apples for the overall Rating refers to the Highest Quality Fund and 5 Apples – Highly Recommended for the investment options means that Chant West believes that the investment option has a very high probability of meeting its stated investment objectives and is likely to deliver strong peer-relative outcomes over the long-term. It also indicates the strategy scores highly across each of Chant West’s key areas of assessment. 

Lonsec

“The Highly Recommended rating indicates that Lonsec has very strong conviction the financial product can generate risk adjusted returns in line with relevant objectives. The financial product is considered a preferred entry point to this asset class or strategy.”

"The Recommended rating indicates that Lonsec has strong conviction the financial product can generate risk adjusted returns in line with relevant objectives. The financial product is considered an appropriate entry point to this asset class or strategy."

Lonsec adopts an investigative research approach, which evaluates a range of criteria including the investment process, people and resources, asset allocation, portfolio construction, risk management, investor focus and commitment. Lonsec’s experienced analysts spend a substantial amount of time with all stakeholders involved in the management of an investment product.

The six level ratings categorisation has three positive ratings including Highly Recommended, Recommended and Investment Grade. Negative ratings include Fund Watch, Redeem or Screened out.

Disclaimers

© Zenith CW Pty Ltd ABN 20 639 121 403 (Chant West), Authorised Representative of Zenith Investment Partners Pty Ltd ABN 27 103 132 672, AFSL 226872 under AFS Representative Number 1280401, 2022. The criteria used by Chant West to judge its awards are subjective ratings that have been determined by us based on data (including historical financial performance information) supplied by third parties. While such information is believed to be accurate, Chant West does not accept responsibility for any inaccuracy in such data. Chant West does not make any representation or give any guarantee or assurance as to the performance or success of any financial product based on the subjective ratings provided. Past performance is not a reliable indicator of future performance. The Chant West awards do not constitute financial product advice, however, to extent that the awards are considered to be advice, it is General Advice (s766B Corporations Act) only. Individuals should seek their own independent financial advice and consider the appropriateness of any financial product in light of their own circumstances and needs before making any investment decision. Chant West has not taken into account the objectives, financial situation or needs of any specific person, including target markets of financial products, where applicable. It is not a specific recommendation to purchase, sell or hold any product(s) and is subject to change at any time without prior notice. Individuals should consider the appropriateness of any advice in light of their own objectives, financial situations or needs and should obtain a copy of and consider any relevant PDS or offer document before making any decision. Ratings are provided in good faith and are believed to be accurate, however, no representation, warranty or undertaking is provided in relation to their accuracy or completeness. Ratings are subject to copyright and may not be reproduced, modified or distributed without the consent of the copyright owner. Except for any liability which cannot be excluded, Chant West does not accept any liability whether direct or indirect, arising from use of the ratings. Past performance is not an indication of future performance. Chant West ratings and research are prepared by Chant West and are not connected in any way to research and ratings prepared by any of our related entities. Full details regarding Chant West’s research methodology, processes, ratings definitions are available at www.chantwest.com.au and Chant West’s Financial Services Guide is available at www.chantwest.com.au/financial-services-guide.

The rating issued May 2024 is published by Lonsec Research Pty Ltd ABN 11 151 658 561 AFSL 421 445 (Lonsec). Ratings are general advice only, and have been prepared without taking account of your objectives, financial situation or needs. Consider your personal circumstances, read the product disclosure statement and seek independent financial advice before investing. The rating is not a recommendation to purchase, sell or hold any product. Past performance information is not indicative of future performance. Ratings are subject to change without notice and Lonsec assumes no obligation to update. Lonsec uses objective criteria and receives a fee from the Fund Manager. Visit lonsec.com.au for ratings information and to access the full report. © 2023 Lonsec. All rights reserved.

For further information regarding Lonsec’s Ratings methodology, please refer to our website at www.lonsec.com.au/our-research-process